{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:31:42Z","timestamp":1790317902227,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2015R1A2A1A13027811"],"award-info":[{"award-number":["2015R1A2A1A13027811"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2013R1A1A2012483"],"award-info":[{"award-number":["2013R1A1A2012483"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.jconrel.2016.02.046","type":"journal-article","created":{"date-parts":[[2016,3,5]],"date-time":"2016-03-05T20:16:05Z","timestamp":1457208965000},"page":"2-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Antitumor effect and safety profile of systemically delivered oncolytic adenovirus complexed with EGFR-targeted PAMAM-based dendrimer in orthotopic lung tumor model"],"prefix":"10.1016","volume":"231","author":[{"given":"A-Rum","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayananda","family":"Kasala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwoo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonsig","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Jung","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chae-Ok","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2016.02.046_bb0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0010","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/cncr.28509","article-title":"Annual report to the nation on the status of cancer, 1975\u20132010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer","volume":"120","author":"Edwards","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2016.02.046_bb0015","doi-asserted-by":"crossref","first-page":"4258s","DOI":"10.1158\/1078-0432.CCR-040023","article-title":"Anti-vascular endothelial growth factor monoclonals in non-small cell lung cancer","volume":"10","author":"Sandler","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0020","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1200\/JCO.2005.08.409","article-title":"Epidermal growth factor receptor inhibitors in the treatment of non-small-cell lung cancer","volume":"23","author":"Giaccone","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0025","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/annonc\/mdu123","article-title":"2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line\/second and further lines of treatment in advanced disease","volume":"25","author":"Besse","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0030","first-page":"603","article-title":"Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression","volume":"7","author":"Ohsaki","year":"2000","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0035","doi-asserted-by":"crossref","first-page":"66","DOI":"10.5858\/2008-0586-RAR1.1","article-title":"Is the epidermal growth factor receptor status in lung cancers reflected in clinicopathologic features?","volume":"134","author":"Inamura","year":"2010","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0040","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrc1609","article-title":"ERBB receptors and cancer: the complexity of targeted inhibitors","volume":"5","author":"Hynes","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2016.02.046_bb0045","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.coviro.2012.07.006","article-title":"The use of oncolytic viruses to overcome lung cancer drug resistance","volume":"2","author":"Beljanski","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0050","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1038\/sj.onc.1210383","article-title":"EGFR kinase domain mutations \u2014 functional impact and relevance for lung cancer therapy","volume":"26","author":"Irmer","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2016.02.046_bb0055","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nrclinonc.2011.45","article-title":"Targeting the human EGFR family in esophagogastric cancer","volume":"8","author":"Okines","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0060","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1158\/1078-0432.CCR-06-0244","article-title":"Eliminating established tumor in nu\/nu nude mice by a tumor necrosis factor-alpha-related apoptosis-inducing ligand-armed oncolytic adenovirus","volume":"12","author":"Dong","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0065","first-page":"515","article-title":"Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression","volume":"3","author":"Rusch","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0070","first-page":"241","article-title":"Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I\u2013IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival","volume":"4","author":"Fontanini","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0075","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1158\/1078-0432.795.11.2","article-title":"The effects of cetuximab alone and in combination with radiation and\/or chemotherapy in lung cancer","volume":"11","author":"Raben","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0080","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.1158\/0008-5472.CAN-04-0562","article-title":"Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor","volume":"64","author":"Huang","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0085","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrd1445","article-title":"Cetuximab","volume":"3","author":"Graham","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0090","first-page":"1311","article-title":"Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model","volume":"1","author":"Goldstein","year":"1995","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0095","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.274.5286.373","article-title":"An adenovirus mutant that replicates selectively in p53-deficient human tumor cells","volume":"274","author":"Bischoff","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2016.02.046_bb0100","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1038\/sj.onc.1204094","article-title":"Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer","volume":"19","author":"Kirn","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2016.02.046_bb0105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/(SICI)1521-2254(200003\/04)2:2<141::AID-JGM93>3.0.CO;2-2","article-title":"Cancer gene therapy\u2014new approaches to tumour cell killing","volume":"2","author":"Vile","year":"2000","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0110","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.18632\/oncotarget.3018","article-title":"Adenovirus expressing dual c-Met-specific shRNA exhibits potent antitumor effect through autophagic cell death accompanied by senescence-like phenotypes in glioblastoma cells","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2016.02.046_bb0115","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1002\/jps.23556","article-title":"Evaluation of cell-penetrating peptide\/adenovirus particles for transduction of CAR-negative cells","volume":"102","author":"Nigatu","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0120","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/ijc.20129","article-title":"Modified adenoviruses for cancer gene therapy","volume":"110","author":"Kanerva","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2016.02.046_bb0125","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jconrel.2013.03.030","article-title":"Therapeutic targeting of chitosan-PEG-folate-complexed oncolytic adenovirus for active and systemic cancer gene therapy","volume":"169","author":"Kwon","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.02.046_bb0130","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/mt.2013.100","article-title":"FX and host defense evasion tactics by adenovirus","volume":"21","author":"Baker","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0135","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1189\/jlb.69.4.622","article-title":"Adenoviral gene delivery can inactivate Kupffer cells: role of oxidants in NF-kappaB activation and cytokine production","volume":"69","author":"Wheeler","year":"2001","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0140","doi-asserted-by":"crossref","first-page":"781","DOI":"10.5483\/BMBRep.2010.43.12.781","article-title":"Current advances in adenovirus nanocomplexes: more specificity and less immunogenicity","volume":"43","author":"Kang","year":"2010","journal-title":"BMB Rep."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0145","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.biomaterials.2010.10.031","article-title":"Active targeting and safety profile of PEG-modified adenovirus conjugated with herceptin","volume":"32","author":"Kim","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.02.046_bb0150","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1021\/nn800279s","article-title":"Adenovirus in a synthetic membrane wrapper: an example of hybrid vigor?","volume":"2","author":"Thompson","year":"2008","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2016.02.046_bb0155","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.tibtech.2009.01.003","article-title":"Designer adenoviruses for nanomedicine and nanodiagnostics","volume":"27","author":"Singh","year":"2009","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0160","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.addr.2009.12.003","article-title":"HPMA copolymers for masking and retargeting of therapeutic viruses","volume":"62","author":"Fisher","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0165","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1021\/mp300366f","article-title":"Adenoviral vectors coated with PAMAM dendrimer conjugates allow CAR independent virus uptake and targeting to the EGF receptor","volume":"10","author":"Vetter","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0170","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.2967\/jnumed.112.115493","article-title":"Systemic image-guided liver cancer radiovirotherapy using dendrimer-coated adenovirus encoding the sodium iodide symporter as theranostic gene","volume":"54","author":"Grunwald","year":"2013","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0175","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.addr.2006.03.007","article-title":"Current status of polymeric gene delivery systems","volume":"58","author":"Park","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0180","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/jgm.237","article-title":"Side-effects of a systemic injection of linear polyethylenimine\u2013DNA complexes","volume":"4","author":"Chollet","year":"2002","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0185","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1002\/ijc.23930","article-title":"Tumor microenvironment: modulation by decorin and related molecules harboring leucine-rich tandem motifs","volume":"123","author":"Goldoni","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2016.02.046_bb0190","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1593\/neo.09760","article-title":"Decorin suppresses prostate tumor growth through inhibition of epidermal growth factor and androgen receptor pathways","volume":"11","author":"Hu","year":"2009","journal-title":"Neoplasia"},{"key":"10.1016\/j.jconrel.2016.02.046_bb0195","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/sj.bjc.6603884","article-title":"Downstream signalling and specific inhibition of c-MET\/HGF pathway in small cell lung cancer: implications for tumour invasion","volume":"97","author":"Ma","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2016.02.046_bb0200","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1089\/hum.2006.167","article-title":"E1A- and E1B-Double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effects","volume":"18","author":"Kim","year":"2007","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0205","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/gt.2009.142","article-title":"Effect of decorin on overcoming the extracellular matrix barrier for oncolytic virotherapy","volume":"17","author":"Choi","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0210","article-title":"A novel sLRP6E1E2 inhibits canonical Wnt signaling, epithelial-to-mesenchymal transition, and induces mitochondria-dependent apoptosis in lung cancer","volume":"7","author":"Lee","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2016.02.046_bb0215","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1073\/pnas.57.5.1302","article-title":"Adenovirus DNA. I. Molecular weight and conformation","volume":"57","author":"Green","year":"1967","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0220","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.biomaterials.2009.10.044","article-title":"Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style","volume":"31","author":"Zhu","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.02.046_bb0225","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1021\/nn900491j","article-title":"Immunolabeling and NIR-excited fluorescent imaging of HeLa cells by using NaYF(4):Yb,Er upconversion nanoparticles","volume":"3","author":"Wang","year":"2009","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2016.02.046_bb0230","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1021\/bc2006219","article-title":"T cell-specific siRNA delivery using antibody-conjugated chitosan nanoparticles","volume":"23","author":"Lee","year":"2012","journal-title":"Bioconjug. Chem."},{"issue":"Pt B","key":"10.1016\/j.jconrel.2016.02.046_bb0235","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jconrel.2015.10.015","article-title":"Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model","volume":"220","author":"Na","year":"2015","journal-title":"J. Control. Release: official journal of the Controlled Release Society"},{"key":"10.1016\/j.jconrel.2016.02.046_bb0240","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jconrel.2011.12.008","article-title":"Linearized oncolytic adenoviral plasmid DNA delivered by bioreducible polymers","volume":"158","author":"Kim","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.02.046_bb0245","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11095-009-9992-1","article-title":"PEGylated PAMAM dendrimer-doxorubicin conjugates: in vitro evaluation and in vivo tumor accumulation","volume":"27","author":"Zhu","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0250","doi-asserted-by":"crossref","first-page":"9396","DOI":"10.1073\/pnas.85.24.9396","article-title":"Charge configurations in viral proteins","volume":"85","author":"Karlin","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0255","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3892\/mco.2014.356","article-title":"Passive targeting of nanoparticles to cancer: a comprehensive review of the literature","volume":"2","author":"Bazak","year":"2014","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0260","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nnano.2008.30","article-title":"Nanoparticle-mediated cellular response is size-dependent","volume":"3","author":"Jiang","year":"2008","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0265","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jconrel.2015.01.005","article-title":"pH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesis","volume":"205","author":"Choi","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.02.046_bb0270","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1016\/j.biomaterials.2014.03.060","article-title":"Enhanced therapeutic efficacy of an adenovirus\u2013PEI\u2013bile-acid complex in tumors with low Coxsackie and adenovirus receptor expression","volume":"35","author":"Lee","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.02.046_bb0275","doi-asserted-by":"crossref","first-page":"40183","DOI":"10.1074\/jbc.M607958200","article-title":"Epidermal growth factor receptor (EGFR) antibody down-regulates mutant receptors and inhibits tumors expressing EGFR mutations","volume":"281","author":"Perez-Torres","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0280","doi-asserted-by":"crossref","first-page":"15767","DOI":"10.1074\/jbc.M500451200","article-title":"Decorin, a novel player in the insulin-like growth factor system","volume":"280","author":"Schonherr","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0285","doi-asserted-by":"crossref","first-page":"42075","DOI":"10.1074\/jbc.M110.172841","article-title":"Decorin antagonizes Met receptor activity and down-regulates {beta}-catenin and Myc levels","volume":"285","author":"Buraschi","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0290","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1158\/1078-0432.CCR-10-0664","article-title":"A hypoxia- and {alpha}-fetoprotein-dependent oncolytic adenovirus exhibits specific killing of hepatocellular carcinomas","volume":"16","author":"Kwon","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0295","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/sj.gt.3301515","article-title":"CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors","volume":"8","author":"Alemany","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0300","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1089\/10430349950018021","article-title":"PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo","volume":"10","author":"O'Riordan","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0305","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ymthe.2004.09.015","article-title":"Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses","volume":"11","author":"Mok","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0310","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/ijc.29536","article-title":"Treatment of melanoma with a serotype 5\/3 chimeric oncolytic adenovirus coding for GM-CSF: results in vitro, in rodents and in humans","volume":"137","author":"Bramante","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2016.02.046_bb0315","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1093\/jnci\/djt305","article-title":"Enhanced tumor uptake and penetration of virotherapy using polymer stealthing and focused ultrasound","volume":"105","author":"Carlisle","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0320","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1756-9966-29-84","article-title":"Development of clinically relevant orthotopic xenograft mouse model of metastatic lung cancer and glioblastoma through surgical tumor tissues injection with trocar","volume":"29","author":"Fei","year":"2010","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0325","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/jgm.1373","article-title":"Systemic adenoviral gene delivery to orthotopic murine breast tumors with ablation of coagulation factors, thrombocytes and Kupffer cells","volume":"11","author":"Koski","year":"2009","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0330","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/mt.2010.229","article-title":"Modifications of adenovirus hexon allow for either hepatocyte detargeting or targeting with potential evasion from Kupffer cells","volume":"19","author":"Prill","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.02.046_bb0335","first-page":"755","article-title":"The ultrastructure of acidophilic \u201cCouncilman-like\u201d bodies in the liver","volume":"48","author":"Klion","year":"1966","journal-title":"Am. J. Pathol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916301109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916301109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T04:04:17Z","timestamp":1692245057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365916301109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":67,"alternative-id":["S0168365916301109"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.02.046","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antitumor effect and safety profile of systemically delivered oncolytic adenovirus complexed with EGFR-targeted PAMAM-based dendrimer in orthotopic lung tumor model","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.02.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}